FPA: Set, Administration, Intravascular
What it covers
An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.
The identification in 21 CFR 880.5440, intravascular administration set. FDA gives FPA no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K254123 | Ecomed Disposable Administration Sets | Ecomed Solutions, LLC | Sep 11, 2026 | Abbreviated |
| K261530 | iiSure Infusion Set | Deka Research and Development | Jun 3, 2026 | Special |
| K252543 | AMSafe Administration Set (BA-70075, BA-70071-D, BA-70070, BA-70071-P, BA-70072, BA-70072-F, BA-70071-DF, BA-70071-DF-120, FE01, FE04) | Amsino International, Inc. | May 4, 2026 | Traditional |
| K251375 | PuraCath Firefly Needleless Connector IT (9005) | Puracath Medical, Inc. | Feb 12, 2026 | Traditional |
| K251257 | nSet+ Stabilization Set [6426733]; nSet+ Stabilization Set with nSyte Needle Free Connector (NFC) [6426731]; nSyte Needle Free Connector (NFC) [6426727] | Np Medical | Dec 4, 2025 | Traditional |
| K250325 | BD Alaris Pump Infusion Set | Carefusion (Bd) | Oct 30, 2025 | Traditional |
| K251814 | EZ IV Administration Set | Epic Medical Pte. , Ltd. | Aug 29, 2025 | Traditional |
| K251854 | SteadiSet infusion set | Tandem Diabetes Care | Aug 6, 2025 | Abbreviated |
| K243841 | Sparta Infusion Set for Insulin | Deka Research and Development | Aug 1, 2025 | Traditional |
| K243392 | Infusomat® Space Volumetric Infusion Pump Administration Sets | B.Braun Medical, Inc. | Jul 24, 2025 | Traditional |
Clearances by year
196 FPA 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 4 | 266 |
| 2025 | 11 | 225 |
| 2024 | 7 | 244 |
| 2023 | 14 | 340 |
| 2022 | 14 | 213 |
| 2021 | 13 | 186 |
| 2020 | 10 | 327 |
| 2019 | 7 | 161 |
| 2018 | 4 | 177 |
| 2017 | 17 | 240 |
| 2016 | 12 | 195 |
| 2015 | 15 | 123 |
| 2014 | 22 | 89 |
| 2013 | 13 | 90 |
| 2012 | 21 | 96 |
| 2011 | 12 | 87 |
Who submits
99 applicants cleared a FPA device since 2011. 69% of the clearances went to applicants in United States, then China (11%), Denmark (3%) and Türkiye (3%). By type: Traditional 80%, Special 16% and Abbreviated 5%. 14 went through a third-party review organization.
| Applicant | Clearances since 2011 |
|---|---|
| Baxter Healthcare Corporation | 16 |
| B.Braun Medical, Inc. | 13 |
| Hospira, Inc. | 11 |
| Quest Medical, Inc. | 7 |
| Care Fusion | 6 |
| Unomedical A/S | 6 |
| Baxter Healthcare Corp | 5 |
| Nexus Medical, LLC | 5 |
How FDA classifies it
Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.
From 21 CFR 880.5440. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 880.5440 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent FPA clearances declared.
Ask about FPA
Questions about FPA
What is FDA product code FPA?
Product code FPA, “Set, Administration, Intravascular” in FDA's classification database, is a Class II device type under 21 CFR 880.5440 (intravascular administration set), reviewed by FDA's General Hospital panel. FDA's 510(k) database lists 1,175 clearances under FPA, 196 of them since 2011.
How many 510(k) clearances are there under FPA?
FDA’s 510(k) database listed 1,175 clearances under FPA as of Oct 29, 2026, 196 of them decided since 2011; the most recent decision was Sep 11, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a FPA 510(k)?
For the 16 FPA clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 232 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most FPA clearances?
Since 2011: Baxter Healthcare Corporation (16), B.Braun Medical, Inc. (13), Hospira, Inc. (11), Quest Medical, Inc. (7) and Care Fusion (6). 99 applicants have cleared a FPA device in that time.